Susquehanna International Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68K | Buy |
163,813
+42,103
| +35% | +$17.5K | ﹤0.01% | 5981 |
|
|
2025
Q1 | $75.8K | Sell |
121,710
-29,910
| -20% | -$18.6K | ﹤0.01% | 5937 |
|
|
2024
Q4 | $253K | Buy |
151,620
+121,272
| +400% | +$203K | ﹤0.01% | 4963 |
|
|
2024
Q3 | $55.2K | Buy |
30,348
+5,787
| +24% | +$10.5K | ﹤0.01% | 5266 |
|
|
2024
Q2 | $148K | Buy |
24,561
+859
| +4% | +$5.18K | ﹤0.01% | 4926 |
|
|
2024
Q1 | $264K | Sell |
23,702
-15,813
| -40% | -$176K | ﹤0.01% | 4348 |
|
|
2023
Q4 | $588K | Sell |
39,515
-12,569
| -24% | -$187K | ﹤0.01% | 3613 |
|
|
2023
Q3 | $250K | Buy |
52,084
+22,675
| +77% | +$109K | ﹤0.01% | 4255 |
|
|
2023
Q2 | $221K | Buy |
29,409
+17,054
| +138% | +$128K | ﹤0.01% | 4553 |
|
|
2023
Q1 | $55.8K | Buy |
+12,355
| New | +$55.8K | ﹤0.01% | 5414 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5791 |
|
|
2022
Q3 | – | Sell |
-25,193
| Closed | -$204K | – | 6088 |
|
|
2022
Q2 | $204K | Sell |
25,193
-30,219
| -55% | -$245K | ﹤0.01% | 4536 |
|
|
2022
Q1 | $936K | Buy |
55,412
+2,542
| +5% | +$42.9K | ﹤0.01% | 2896 |
|
|
2021
Q4 | $1.14M | Buy |
52,870
+37,018
| +234% | +$795K | ﹤0.01% | 2689 |
|
|
2021
Q3 | $1.17M | Sell |
15,852
-6,309
| -28% | -$466K | ﹤0.01% | 2575 |
|
|
2021
Q2 | $1.21M | Sell |
22,161
-13,089
| -37% | -$716K | ﹤0.01% | 2718 |
|
|
2021
Q1 | $2.6M | Buy |
35,250
+30,068
| +580% | +$2.22M | ﹤0.01% | 1828 |
|
|
2020
Q4 | $447K | Buy |
+5,182
| New | +$447K | ﹤0.01% | 3522 |
|